StockData
uniQure N.V. logo

uniQure N.V. (QURE) stock

QURENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 4/30224% above fair value
$20.30−0.48 (-2.31%)

Close on Nov 18, 2026Market cap $1.41BP/E –Yield –

uniQure operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

uniQure's operating cash flow for the twelve months ending Jun 30, 2026 was -$160.79M. For fiscal 2025 it was -$177.96M. The highest annual figure on record is $287.96M in fiscal 2021.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$177.96M–
FY2024Dec 31, 2024-$182.73M–
FY2023Dec 31, 2023-$145.93M–
FY2022Dec 31, 2022-$145.06M-150.4%
FY2021Dec 31, 2021$287.96M–
FY2020Dec 31, 2020-$134.83M–
FY2019Dec 31, 2019-$98.68M–
FY2018Dec 31, 2018-$76.04M–
FY2017Dec 31, 2017-$64.27M–
FY2016Dec 31, 2016-$72.19M-1066.6%
FY2015Dec 31, 2015$7.47M–
FY2014Dec 31, 2014-$36.85M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$28.58M–
Q1 FY2026Mar 31, 2026-$38.24M–
Q4 FY2025Dec 31, 2025-$77.57M–
Q3 FY2025Sep 30, 2025-$16.40M–
Q2 FY2025Jun 30, 2025-$39.90M–
Q1 FY2025Mar 31, 2025-$44.10M–
Q4 FY2024Dec 31, 2024-$52.84M–
Q3 FY2024Sep 30, 2024-$36.60M-194.1%
Q2 FY2024Jun 30, 2024-$32.71M–
Q1 FY2024Mar 31, 2024-$60.58M–
Q4 FY2023Dec 31, 2023-$49.54M–
Q3 FY2023Sep 30, 2023$38.91M–
Q2 FY2023Jun 30, 2023-$57.00M–
Q1 FY2023Mar 31, 2023-$78.30M–
Q4 FY2022Dec 31, 2022-$54.68M–
Q3 FY2022Sep 30, 2022-$48.99M–
Q2 FY2022Jun 30, 2022-$15.68M-103.8%
Q1 FY2022Mar 31, 2022-$25.71M–
Q4 FY2021Dec 31, 2021-$47.09M–
Q3 FY2021Sep 30, 2021-$40.16M–
Q2 FY2021Jun 30, 2021$416.48M–
Q1 FY2021Mar 31, 2021-$41.27M–
Q4 FY2020Dec 31, 2020-$37.18M–
Q3 FY2020Sep 30, 2020-$34.71M–
Q2 FY2020Jun 30, 2020-$29.99M–
Q1 FY2020Mar 31, 2020-$32.95M–
Q4 FY2019Dec 31, 2019-$26.01M–
Q3 FY2019Sep 30, 2019-$22.02M–
Q2 FY2019Jun 30, 2019-$24.22M–
Q1 FY2019Mar 31, 2019-$26.44M–
Q4 FY2018Dec 31, 2018-$18.00M–
Q3 FY2018Sep 30, 2018-$20.06M–
Q2 FY2018Jun 30, 2018-$16.54M–
Q1 FY2018Mar 31, 2018-$21.44M–
Q4 FY2017Dec 31, 2017-$18.05M–
Q3 FY2017Sep 30, 2017-$15.42M–
Q2 FY2017Jun 30, 2017-$19.14M–
Q1 FY2017Mar 31, 2017-$11.67M–
Q4 FY2016Dec 31, 2016-$15.67M–
Q3 FY2016Sep 30, 2016-$18.05M–

More uniQure figures

See a number that looks wrong?